Kreis Leslie W.

Kreis Leslie W. is listed in filings as 10% Owner at Lantern Pharma Inc.. This profile follows SEC Form 4 activity through Jun 30, 2025, including sale activity and purchase activity. Recent filings connect the profile to Lantern Pharma Inc. (LTRN), Cognition Therapeutics, Inc. (CGTX), and Actuate Therapeutics Inc (ACTU). The current snapshot covers public activity from May 29, 2025 to Jun 30, 2025. Reported amounts are shown as $2.9K to $3.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.